China Justice Observer

中司观察

EnglishArabicChinese (Simplified)DutchFrenchGermanHindiItalianJapaneseKoreanPortugueseRussianSpanishSwedishHebrewIndonesianVietnameseThaiTurkishMalay

China to Regulate Aesthetic Medicine Industry

Fri, 07 Jul 2023
Categories: China Legal Trends

avatar

On 4 May 2023, China’s State Administration for Market Regulation (SAMR) issued the “Guiding Opinions on Further Strengthening the Regulation of the Aesthetic Medicine Industry” (hereinafter the “Guiding Opinions”, 关于进一步加强医疗美容行业监管工作的指导意见).

The highlights of the Guiding Opinions are as follows:

  • Health administrative departments issue licenses for aesthetic medicine services and provide channels for the public to access information on such licenses.
  • Subjects engaged in the business of aesthetic medicine diagnosis and treatment consultation as well as medical treatment guidance are not allowed to provide diagnosis, treatment consultation, and medical treatment guidance services to unlicensed cosmetology institutions.
  • A distinction is made between cosmetology and aesthetic medicine. Cosmetology institutions may not engage in medical aesthetic activities directly or in a disguised manner.

 

Photo by Spacejoy on Unsplash

Contributors: CJO Staff Contributors Team

Save as PDF

You might also like

Guangdong High Court Highlights Landmark Mainland-Hong Kong Bankruptcy Ruling

Among 10 typical cases released by the Guangdong High People's Court to advance legal alignment in the Greater Bay Area, a landmark ruling (Re Guangdong Overseas Construction Corporation) stands out for securing Hong Kong judicial recognition for a bankruptcy administrator appointed by a mainland court outside designated pilot regions.

China Publishes First Typical Cases in Sports Arbitration

China Commission of Arbitration for Sports (CCAS) has released its first set of six typical cases, establishing a precedent, among others, that sports agency contract disputes fall under specialized sports arbitration rather than general commercial arbitration.

China Designates Beijing Court for ICSID Arbitral Awards

China has officially designated the Beijing No. 4 Intermediate People's Court to handle the recognition and enforcement of ICSID awards, filling a long-standing procedural gap and advancing its restrictive immunity framework.

PRC Double Interest neither Double nor Penal, Australian Courts Clear Its Name When Enforcing Chinese Judgments

Recent Australian case law clarifies that the “double interest” mechanism in the People’s Republic of China (PRC) monetary judgments functions as a compensatory post-judgment interest framework rather than an unenforceable penalty. This consolidates Australia’s position as a highly attractive and creditor-friendly forum for enforcing Chinese judgments. See Zhengzhou Lvdu Real Estate Group Co v Shu [2024] NSWSC 58 (6 February 2024), Fu v Pang [2025] VSC 597 (16 September 2025)